Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Re-treatment in RA
NCT02097745Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2004
- Primary completion
- Jun 2013
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Jun 2004; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02097745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097745.